Abstract:Resting mature human B cells undergo a dynamic process of clonal expansion, followed by clonal contraction, during an in vitro response to surrogate C3d-coated Ag and innate immune system cytokines, IL-4 and BAFF. In this study, we explore the mechanism for clonal contraction through following the time- and division-influenced expression of several pro- and anti-apoptotic proteins within CFSE-labeled cultures. Several findings, involving both human and mouse B cells, show that a mitochondria-dependent apoptotic pathway involving p53 contributes to the high activation-induced cell death (AICD) susceptibility of replicating blasts. Activated B cell clones exhibit elevated p53 protein and elevated mRNA/protein of proapoptotic molecules known to be under direct p53 transcriptional control, Bax, Bad, Puma, Bid, and procaspase 6, accompanied by reduced anti-apoptotic Bcl-2. Under these conditions, Bim levels were not increased. The finding that full-length Bid protein significantly declines in AICD-susceptible replicating blasts, whereas Bid mRNA does not, suggests that Bid is actively cleaved to short-lived, proapoptotic truncated Bid. AICD was diminished, albeit not eliminated, by p53 small interfering RNA transfection, genetic deletion of p53, or Bcl-2 overexpression. DNA damage is a likely trigger for p53-dependent AICD because susceptible lymphoblasts expressed significantly elevated levels of both phosphorylated ataxia telangiectasia mutated-Ser(1980) and phospho-H2AX-Ser(139). Deficiency in activation-induced cytosine deaminase diminishes but does not ablate murine B cell AICD, indicating that activation-induced cytosine deaminase-induced DNA damage is only in part responsible. Evidence for p53-influenced AICD during this route of T cell-independent clonal expansion raises the possibility that progeny bearing p53 mutations might undergo positive selection in peripherally inflamed tissues with elevated levels of IL-4 and BAFF.

Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function

PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

PI3K- and PTEN-Governed PIP2 and PIP3 Equilibrium Regulates the Activation and Function of B Cells Through Dock2 Controlled Growth of Antigen Receptor Microclusters

PTEN-Regulated AID Transcription in Germinal Center B Cells is Essential for the Class-Switch Recombination and IgG Antibody Responses

Abstract 2988: Loss of Rbm38 Cooperates with Mutant P53 to Promote Lymphomagenesis Through Downregulation of Pten

Reduced PTEN involved in primary immune thrombocytopenia via contributing to B cell hyper-responsiveness

PTEN Directs Developmental and Metabolic Signaling for Innate-Like T Cell Fate and Tissue Homeostasis.

Pten Is A Tumor Suppressor In Cml Stem Cells And Bcr-Abl-Induced Leukemias In Mice

C-Terminal Pten Is Essential For Maintenance Of Genomic Stability And Tumor Suppression

Pten Loss in Hematopoietic Stem Cells Leads to A Myeloproliferative Disorder

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

The Phosphatase PTEN Links Platelets with Immune Regulatory Functions of Mouse T Follicular Helper Cells.

PTEN Regulates Hematopoietic Lineage Plasticity Via PU.1-dependent Chromatin Accessibility.

PTEN C-terminal Deletion Causes Genomic Instability and Tumor Development.

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer

A p53 Axis Regulates B Cell Receptor-Triggered, Innate Immune System-Driven B Cell Clonal Expansion

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis

Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafish

Discrete Roles and Bifurcation of PTEN Signaling and Mtorc1-Mediated Anabolic Metabolism Underlie IL-7-driven B Lymphopoiesis